Mesoblast Ltd
F:LWB1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mesoblast Ltd
F:LWB1
|
AU |
|
B
|
BYD Co Ltd
DUS:BY6
|
CN |
|
F
|
Fresenius SE & Co KGaA
XMUN:FRE
|
DE |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
C
|
CapitaLand Integrated Commercial Trust
XMUN:M3T
|
SG |
|
S
|
Saul Centers Inc
F:SA4
|
US |
|
C
|
Corcept Therapeutics Inc
XMUN:HTD
|
US |
|
8
|
8x8 Inc
SWB:EGT
|
US |
|
Olema Pharmaceuticals Inc
NASDAQ:OLMA
|
US |
|
C
|
Compagnie de Saint Gobain SA
XHAM:GOB
|
FR |
|
NIO Inc
NYSE:NIO
|
CN |
|
B
|
Banco Santander SA
DUS:BSD2
|
ES |
|
P
|
Panasonic Holdings Corp
F:MAT1
|
JP |
|
P
|
PICC Property and Casualty Co Ltd
F:PJC
|
CN |
|
Grupo Aeroportuario del Pacifico SAB de CV
BMV:GAPB
|
MX |
|
Kraft Heinz Co
NASDAQ:KHC
|
US |
|
Procter & Gamble Co
NYSE:PG
|
US |
|
Ameris Bancorp
NYSE:ABCB
|
US |
|
E
|
Endeavour Silver Corp
NYSE:EXK
|
CA |
|
Resmed Inc
NYSE:RMD
|
US |
|
C
|
Cardinal Health Inc
SWB:CLH
|
US |
|
Nippon Sanso Holdings Corp
OTC:TYNPF
|
JP |
|
U
|
Unum Group
DUS:UUM
|
US |
|
F
|
Fuji Electric Co Ltd
DUS:FJE
|
JP |
Wall St Price Targets
LWB1 Price Targets Summary
Mesoblast Ltd
According to Wall Street analysts, the average 1-year price target for
LWB1 is 22.74 EUR with a low forecast of 18.34 EUR and a high forecast of 29.26 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LWB1's stock price target?
Price Target
22.74
EUR
According to Wall Street analysts, the average 1-year price target for
LWB1 is 22.74 EUR with a low forecast of 18.34 EUR and a high forecast of 29.26 EUR.
What is the Revenue forecast for Mesoblast Ltd?
Projected CAGR
72%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 72%.
What is the Gross Profit forecast for Mesoblast Ltd?
Projected CAGR
58%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 58%.